appointments

Sales & Marketing

In the agency and investor worlds, August and September hires were light volume-wise, but did include big changes at the top of the totem pole.

Digital

There was plenty of personnel action in August and September among pharmaceutical suppliers, particularly in the clinical trial technology sector.

News

Organon CEO Kevin Ali has stepped down after an audit found sales of the company's Nexplanon contraceptive implant in the US were inflated.

Sales & Marketing

It’s been a busy couple of months in the world of pharma hires as Merck KGaA and GSK both made some big changes at the top.

News

The ousted former director of CBER, Peter Marks, has joined Eli Lilly as head of molecular discovery and infectious disease research.

News

This week has kicked off with the news that Emma Walmsley is standing down as chief executive of GSK after eight years, to be replaced by Luke Miels.